PRE

Rt-Qpcr Assay For Mrna Transcript Immune Biomarkers

Product code
PRE
Device name
Rt-Qpcr Assay For Mrna Transcript Immune Biomarkers
Device class
Class 2
21 CFR
21 CFR 866.3215
Medical specialty
Microbiology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
2
Summaries archived here
1 (direct download)
510(k) clearances (all years, FDA)
4 (all years; only the last 3 years are listed here)

FDA classification definition

A quantitative gene expression assay using reverse transcription polymerase chain reaction to quantify the relative expression levels of host response genes isolated from whole blood.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (2)

Last three years. Most recent: 2025-01-10.

NumberDecision dateApplicantDevice nameSummary
K2416762025-01-10Inflammatix, Inc.TriVerityPDF
K2320952023-12-15Immunexpress, Inc.SeptiCyte RAPID

1 summaries are archived here for direct download.

Official FDA classification page: PRE
Classification and pathway per current FDA publications. Data from openFDA (CC0).